Host: Chris Lord, The Institute of Cancer Research
Date and time: Tue 07-Nov-2017, 11:00-12:30
Room: Default Location
Tumour-specific defects in the DNA damage response network (DDR) not only drive the development of cancer but also present opportunities for therapeutic intervention. In this symposium, we will discuss recent developments in the basic understanding of the DDR, efforts to target the DDR as a therapeutic approach and emerging mechanisms of resistance to DDR inhibitors.
Alan D’Andrea, Center for DNA Damage and Repair (CDDR), Harvard Medical School and Dana-Farber Cancer Institute, USA
Judith Balmaña, Head of the High Risk and Cancer Prevention Group, VHIO, Barcelona, Spain
Laurence Pearl, University of Sussex, UK